WONG RODERICK
SEC CIK 1493280 · EDGAR
BoughtSold
Most active insiders at RCKT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Wilson Martin | GC | — | $334.6K |
| 2 | Shah Gaurav | CEO, Dir | — | $285.6K |
| 3 | Militello John | See Remarks | — | $138.3K |
| 4 | Stevens Christopher James | COO | — | $128.3K |
| 5 | Chaudhuri Sarbani | See Remarks | — | $84.2K |
| 6 | Bjork Elisabeth | Dir | $34.4K | — |
| 7 | Schwartz Jonathan David | See Remarks | — | $7,584 |
| 8 | Fong Peter | Dir | — | — |
| 9 | Rizvi Syed Ali-aamir | Chief Medical Off | — | — |
| 10 | Malik Fady Ibraham | Dir | — | — |
| 11 | WONG RODERICK | Dir, 10% | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-07-06 20:00 | 2026-06-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | WONG RODERICK | Dir, 10% | A - Grant | $0.00 | +27.8K | 75.5K | +58% | $0 |
| M | 2025-07-18 | 2025-06-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | WONG RODERICK | Dir, 10% | A - Grant | $0.00 | +47.7K | 47.7K | New | $0 |
| I | 2025-05-01 | 2025-04-30 | OBIO | Orchestra BioMed Holdings, Inc. | WONG RODERICK | 10% | P - Purchase | $2.99 | +49.9K | 8.31M | +0.6% | +$149.2K |
| I | 2023-03-24 | 2023-03-22 | MIST | Milestone Pharmaceuticals Inc. | WONG RODERICK | 10% | J - Other | — | -1.06M | 3.26M | -25% | — |
| I | 2023-01-26 | 2023-01-24 | OBIO | Orchestra BioMed Holdings, Inc. | WONG RODERICK | CEO, Dir, 10% | P - Purchase | $10.00 | +1.81M | 2.81M | +181% | +$18.09M |
| I | 2022-07-25 | 2022-07-22 | OBIO | Orchestra BioMed Holdings, Inc. | WONG RODERICK | CEO, Dir | P - Purchase | $10.01 | +1.00M | 1.00M | New | +$10.01M |
| I | 2021-08-31 | 2021-08-27 | RCKT | ROCKET PHARMACEUTICALS, INC. | WONG RODERICK | Dir, 10% | A - Grant | $32.48 | +812.5K | 16.27M | +5% | +$26.39M |
Purchase Sale Sale after option exercise All abbreviations